<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">biomolecules</journal-id>
      <journal-title>Biomolecules</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Biomolecules</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Biomolecules</abbrev-journal-title>
      <issn pub-type="epub">2218-273X</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/biom5031319</article-id>
      <article-id pub-id-type="publisher-id">biomolecules-05-01319</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>High-Resolution Respirometry for Simultaneous Measurement of Oxygen and Hydrogen Peroxide Fluxes in Permeabilized Cells, Tissue Homogenate and Isolated Mitochondria</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Makrecka-Kuka</surname>
            <given-names>Marina</given-names>
          </name>
          <xref rid="af1-biomolecules-05-01319" ref-type="aff">1</xref>
          <xref rid="fn1-biomolecules-05-01319" ref-type="fn">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krumschnabel</surname>
            <given-names>Gerhard</given-names>
          </name>
          <xref rid="af2-biomolecules-05-01319" ref-type="aff">2</xref>
          <xref rid="fn1-biomolecules-05-01319" ref-type="fn">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gnaiger</surname>
            <given-names>Erich</given-names>
          </name>
          <xref rid="af2-biomolecules-05-01319" ref-type="aff">2</xref>
          <xref rid="af3-biomolecules-05-01319" ref-type="aff">3</xref>
          <xref rid="c1-biomolecules-05-01319" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Breitenbach</surname>
            <given-names>Michael</given-names>
          </name>
		  <role>Academic Editor</role>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Eckl</surname>
            <given-names>Peter</given-names>
          </name>
		  <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-biomolecules-05-01319"><label>1</label>Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Riga LV1006, Latvia; E-Mail: <email>makrecka@biomed.lu.lv</email></aff>
      <aff id="af2-biomolecules-05-01319"><label>2</label>OROBOROS INSTRUMENTS, Innsbruck 6020, Austria; E-Mail: <email>Gerhard.Krumschnabel@oroboros.at</email></aff>
      <aff id="af3-biomolecules-05-01319"><label>3</label>Daniel Swarovski Research Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck 6020, Austria</aff>
      <author-notes>
        <fn id="fn1-biomolecules-05-01319">
          <label>&#x2020;</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
        <corresp id="c1-biomolecules-05-01319"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>erich.gnaiger@i-med.ac.at</email>; Tel.: +43-512-566796; Fax: +43-512-566796-20.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>06</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">        <month>09</month>
        <year>2015</year>
      </pub-date>
      <volume>5</volume>
      <issue>3</issue>
      <fpage>1319</fpage>
      <lpage>1338</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>04</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>06</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>Whereas mitochondria are well established as the source of ATP in oxidative phosphorylation (OXPHOS), it is debated if they are also the major cellular sources of reactive oxygen species (ROS). Here we describe the novel approach of combining high-resolution respirometry and fluorometric measurement of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) production, applied to mitochondrial preparations (permeabilized cells, tissue homogenate, isolated mitochondria). The widely used H<sub>2</sub>O<sub>2</sub> probe Amplex Red inhibited respiration in intact and permeabilized cells and should not be applied at concentrations above 10 &#xB5;M. H<sub>2</sub>O<sub>2</sub> fluxes were generally less than 1% of oxygen fluxes in physiological substrate and coupling states, specifically in permeabilized cells. H<sub>2</sub>O<sub>2</sub> flux was consistently highest in the Complex II-linked LEAK state, reduced with CI&amp;II-linked convergent electron flow and in mitochondria respiring at OXPHOS capacity, and were further diminished in noncoupled mitochondria respiring at electron transfer system capacity. Simultaneous measurement of mitochondrial respiration and H<sub>2</sub>O<sub>2</sub> flux requires careful optimization of assay conditions and reveals information on mitochondrial function beyond separate analysis of ROS production.</p>
      </abstract>
      <kwd-group>
        <kwd>high-resolution respirometry</kwd>
        <kwd>H<sub>2</sub>O<sub>2</sub> flux</kwd>
        <kwd>Amplex Red</kwd>
        <kwd>HEK 293T</kwd>
        <kwd>mouse brain homogenate</kwd>
        <kwd>mouse cardiac mitochondria</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>1. Introduction</title>
      <p>Mitochondrial reactive oxygen species (ROS) production contributes to both physiological and pathological processes and is essential in cell life and death decisions [<xref ref-type="bibr" rid="B1-biomolecules-05-01319">1</xref>]. At low concentrations ROS promote the adaptation of cells to stress conditions by the regulation of oxidative metabolism, cellular differentiation and autophagy, thus supporting cell survival. Cellular concentrations of ROS are tightly regulated by cellular antioxidant defense systems. When the cellular antioxidant capacity is overwhelmed, ROS concentrations may increase dramatically and the resulting oxidative stress can cause substantial cell damage and ultimately cell death. Hence, both oxidative stress originating from mitochondrial activity and mitochondrial dysfunction ensuing from related oxidative damage have been shown to play important roles in aging and the pathogenesis of various disease states such as ischemia, neurodegeneration, diabetes and atherosclerosis (reviewed in [<xref ref-type="bibr" rid="B2-biomolecules-05-01319">2</xref>,<xref ref-type="bibr" rid="B3-biomolecules-05-01319">3</xref>,<xref ref-type="bibr" rid="B4-biomolecules-05-01319">4</xref>]).</p>
      <p>The magnitude of mitochondrial (mt) ROS production depends on the tissue type, the substrates metabolized, and the site of the mitochondrial electron transfer system (ETS) involved [<xref ref-type="bibr" rid="B5-biomolecules-05-01319">5</xref>]. For the ETS it is quite generally agreed that Complexes I and III, but also the electron-transferring flavoprotein and glycerophosphate dehydrogenase complexes are the main sites of ROS production, particularly under conditions of high mt-membrane potential (reviewed in [<xref ref-type="bibr" rid="B6-biomolecules-05-01319">6</xref>,<xref ref-type="bibr" rid="B7-biomolecules-05-01319">7</xref>]). The primary chemical species of ROS produced by mitochondrial activity appears to be the superoxide anion, most of which is immediately converted to H<sub>2</sub>O<sub>2</sub> by mitochondrial superoxide dismutase (MnSOD). ROS formation, therefore, can be detected with probes sensitive to H<sub>2</sub>O<sub>2</sub>. Hydrogen peroxide is comparatively stable and, due to its membrane permeability, accessible to such probes. Most of the studies investigating mtROS formation have been performed on isolated mitochondria, as methods employed in animals or cultured cells are considered to not provide accurate and quantitative results [<xref ref-type="bibr" rid="B8-biomolecules-05-01319">8</xref>]. It is important, however, to relate these measurements to ROS production of mitochondria within their physiological microenvironment of the cell under actual <italic>in vivo</italic> conditions [<xref ref-type="bibr" rid="B9-biomolecules-05-01319">9</xref>]. Furthermore, measurements of ROS formation are typically conducted in fluorometer cuvettes using buffers optimized for this purpose and generally not identical with the medium applied for determination of mitochondrial respiratory activity. This makes it impossible to accurately correlate ROS formation and mitochondrial energetics under identical conditions imposing a major uncertainty in fluorometric experiments. Continuous measurements of mitochondrial ROS production reported so far were almost always restricted to rather limited time periods of no more than 15 min [<xref ref-type="bibr" rid="B10-biomolecules-05-01319">10</xref>,<xref ref-type="bibr" rid="B11-biomolecules-05-01319">11</xref>,<xref ref-type="bibr" rid="B12-biomolecules-05-01319">12</xref>,<xref ref-type="bibr" rid="B13-biomolecules-05-01319">13</xref>,<xref ref-type="bibr" rid="B14-biomolecules-05-01319">14</xref>] during which it is hardly possible to accurately evaluate multiple mitochondrial substrate and coupling states.</p>
      <p>To overcome some of these limitations, we have recently characterized experimental and technical conditions required for the simultaneous determination of mitochondrial oxygen and H<sub>2</sub>O<sub>2</sub> fluxes using the OROBOROS O2k-Fluorometer based on the Oxygraph-2k for high-resolution respirometry and the O2k-Fluo LED2-Module for the detection of H<sub>2</sub>O<sub>2</sub> by Amplex<sup>&#xAE;</sup> UltraRed [<xref ref-type="bibr" rid="B15-biomolecules-05-01319">15</xref>]. In the present study we extended this approach to show applications for investigating H<sub>2</sub>O<sub>2</sub> flux in permeabilized HEK 293T cells, mouse brain homogenate, and isolated mouse heart mitochondria as experimental models, with application of substrate-uncoupler-inhibitor titration (SUIT) protocols to interrogate sequentially different substrate and coupling states (<xref ref-type="table" rid="biomolecules-05-01319-t001">Table 1</xref>).</p>
      <table-wrap id="biomolecules-05-01319-t001" position="float">
        <object-id pub-id-type="pii">biomolecules-05-01319-t001_Table 1</object-id>
        <label>Table 1</label>
        <caption>
          <p>Definitions of Substrate States and Coupling States used to Characterize Mitochondrial Energetics.</p>
        </caption>
        <table>
  <thead>
            <tr>
              <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">Abbreviation</th>
              <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">Definition</th>
            </tr>
  </thead>
  <tbody>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin"><bold>CI-linked</bold></td>
              <td align="left" valign="middle" style="border-bottom:solid thin">The Complex I-linked substrate state is induced in mt-preparations by addition of NADH-generating substrates.</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin"><bold>CII-linked</bold></td>
              <td align="left" valign="middle" style="border-bottom:solid thin">The Complex II-linked substrate state is induced in mt-preparations by addition of succinate and rotenone (Complex I inhibitor).</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin"><bold>CI&amp;II-linked</bold></td>
              <td align="left" valign="middle" style="border-bottom:solid thin">The Complex I&amp;II-linked substrate state is induced in mt-preparations by addition of NADH-generating substrates (CI-linked) in combination with succinate (CII-linked). This physiological substrate combination is required for partial reconstitution of TCA cycle function and convergent electron-input into the Q-junction to compensate for metabolite depletion into the incubation medium. An additive effect of convergent CI&amp;II-linked electron flow is observed in most types of mitochondria.</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin"><bold><italic>R</italic></bold> </td>
              <td align="left" valign="middle" style="border-bottom:solid thin">In the intact cell, ROUTINE respiration or ROUTINE activity in the physiological coupling state <italic>R</italic> is controlled by cellular energy demand, energy turnover and the degree of coupling to phosphorylation of ADP (intrinsic uncoupling and pathological dyscoupling; [<xref ref-type="bibr" rid="B16-biomolecules-05-01319">16</xref>]).</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin"><bold><italic>L</italic></bold> </td>
              <td align="left" valign="middle" style="border-bottom:solid thin">LEAK respiration or LEAK oxygen flux compensating for proton leak, proton slip, cation cycling and electron leak, is a dissipative component of respiration which is not available for performing biochemical work and thus related to heat production. LEAK respiration is measured in state <italic>L</italic>, in the presence of reducing substrate(s), but absence of ADP (theoretically, absence of inorganic phosphate presents an alternative), or after enzymatic inhibition of the phosphorylation system. In this non-phosphorylating resting state, the electrochemical proton gradient is increased to a maximum, exerting feedback control by depressing oxygen flux to a level determined mainly by the proton leak and the H<sup>+</sup>/O<sub>2</sub> ratio [<xref ref-type="bibr" rid="B17-biomolecules-05-01319">17</xref>].</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin"><bold><italic>P</italic></bold> </td>
              <td align="left" valign="middle" style="border-bottom:solid thin">OXPHOS capacity is the respiratory capacity of mitochondria in the ADP-activated state of oxidative phosphorylation, at saturating concentrations of ADP, inorganic phosphate, oxygen, and defined reduced substrates [<xref ref-type="bibr" rid="B17-biomolecules-05-01319">17</xref>]. It thus differs from State 3 respiration which is respiration of isolated coupled mitochondria in the presence of high ADP and Pi concentrations [<xref ref-type="bibr" rid="B18-biomolecules-05-01319">18</xref>]. ADP concentrations applied in State 3 are not necessarily saturating, whereas OXPHOS capacity is measured at saturating concentrations of ADP and Pi.</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin"><bold><italic>E</italic></bold> </td>
              <td align="left" valign="middle" style="border-bottom:solid thin">The mitochondrial electron transfer system (ETS) transfers electrons from externally supplied reduced substrates to oxygen. It consists of the membrane-bound ETS (mETS) with enzyme complexes located in the inner mt-membrane, mt-matrix dehydrogenases generating NADH, and the transport systems involved in metabolite exchange across the mt-membranes [<xref ref-type="bibr" rid="B19-biomolecules-05-01319">19</xref>]. ETS capacity is max. O<sub>2</sub> flux at optimum uncoupler concentration.</td>
            </tr>
  </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="results">
      <title>2. Results and Discussion</title>
      <sec>
        <title>2.1. Effect of Amplex Red on Respiration of Intact and Permeabilized HEK 293T Cells</title>
        <p>The use of Amplex Red or Amplex UltraRed (AmR) at concentrations up to 50 &#xB5;M is suggested by commercial suppliers for the determination of H<sub>2</sub>O<sub>2</sub> production, but much lower concentrations down to 1 &#xB5;M have been applied successfully [<xref ref-type="bibr" rid="B12-biomolecules-05-01319">12</xref>,<xref ref-type="bibr" rid="B13-biomolecules-05-01319">13</xref>,<xref ref-type="bibr" rid="B14-biomolecules-05-01319">14</xref>,<xref ref-type="bibr" rid="B20-biomolecules-05-01319">20</xref>,<xref ref-type="bibr" rid="B21-biomolecules-05-01319">21</xref>]. Since some fluorescence probes, e.g., mitochondrial membrane potential sensitive dyes (safranin, rhodamine), inhibit mitochondrial respiration [<xref ref-type="bibr" rid="B22-biomolecules-05-01319">22</xref>,<xref ref-type="bibr" rid="B23-biomolecules-05-01319">23</xref>], we considered it advisable to check for such undesired effects and to evaluate the optimal concentration of AmR prior to the actual experimental series. The dose-dependent effect of AmR on mitochondrial respiration is shown in <xref ref-type="fig" rid="biomolecules-05-01319-f001">Figure 1</xref> and <xref ref-type="fig" rid="biomolecules-05-01319-f002">Figure 2</xref> for intact and permeabilized HEK 293T cells.</p>
        <fig id="biomolecules-05-01319-f001" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Effect of Amplex UltraRed (AmR) on respiration of intact HEK 293T cells. (<bold>A</bold>) Representative respiratory experiment with AmR or carrier DMSO titrated in the ROUTINE state. Oxygen concentration (blue plot; left <italic>Y</italic>-axis [&#xB5;M]) is shown for one chamber, whereas oxygen fluxes per chamber volume (red and green plots; right <italic>Y</italic>-axis [pmol&#xB7;s<sup>&#x2212;1</sup>&#xB7;mL<sup>&#x2212;1</sup>]) are depicted for both O2k-chambers operated simultaneously. The horizontal bar denotes the respiratory states, ROUTINE; LEAK state, <italic>L</italic>; progressively uncoupled states in which ETS capacity is reached at maximum flux; and residual oxygen consumption, ROX. Numbers indicate final AmR concentrations [&#xB5;M]; U0.5, U5 and U10 indicate final uncoupler concentrations [&#xB5;M], added in 0.5 &#xB5;M steps between 0.5 and 5 &#xB5;M and 1 &#xB5;M steps between 5 and 10 &#xB5;M. Discontinuities of the plots are due to removal of sections with artifacts arising from titrations or re-oxygenations; (<bold>B</bold>) Oxygen flow expressed as respiration per million cells [pmol&#xB7;s<sup>&#x2212;1</sup>&#xB7;10<sup>&#x2212;6</sup> cells], mean &#xB1; SE of <italic>N</italic> = 3&#x2013;5 independent cultures, each measured in duplicate (<italic>n</italic> = 2).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biomolecules-05-01319-g001.tif"/>
        </fig>
        <fig id="biomolecules-05-01319-f002" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Effect of AmR on respiration of permeabilized HEK 293T cells. (<bold>A</bold>) Representative experiment with AmR (green plot) or carrier DMSO (red plot) titrated in the CI&amp;II-linked OXPHOS state. Substrate states and coupling states are shown by horizontal bars. Numbers indicate final Amp concentrations [&#xB5;M]; U1 and U5 indicate final uncoupler concentrations [&#xB5;M] added in 1 &#xB5;M steps; (<bold>B</bold>) Oxygen flow [pmol&#x2219;s<sup>&#x2212;1</sup>&#xB7;10<sup>&#x2212;6</sup> cells], mean &#xB1; SE of <italic>N</italic> = 5 independent cultures, each measured in duplicate (<italic>n</italic> = 2).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biomolecules-05-01319-g002.tif"/>
        </fig>
        <p>In the experiments with intact cells titrations with AmR were conducted in the ROUTINE state of respiration. ROUTINE respiration was not completely stable in controls for the duration of the carrier titrations (DMSO) which lasted approximately 35 min. Titration of AmR caused a slight but non-significant further reduction of ROUTINE respiration by up to 8% at 30 &#xB5;M compared to time-matched controls (<xref ref-type="fig" rid="biomolecules-05-01319-f001">Figure 1</xref>B). Subsequent addition of oligomycin induced an immediate inhibition of respiration, and LEAK respiration was indistinguishable between both groups. To obtain a measure for ETS, <italic>i.e.</italic>, the maximal capacity of the electron transfer system under the conditions examined, a step-by-step titration with uncoupler CCCP was performed showing that AmR caused a slight but variable, on average insignificant reduction of ETS capacity. Residual oxygen consumption, ROX, obtained after inhibition of Complexes I and III by rotenone (Rot) and antimycin A (Ama), respectively, was identical in controls and AmR-treated cells. Taken together, these results suggest that AmR may be used at concentrations up to 30 &#xB5;M to determine H<sub>2</sub>O<sub>2</sub> production in intact HEK 293T cells with minor side effects on respiration. Exposure of these cells to 20 &#xB5;M AmR for more than 45 min, however, caused about 13% inhibition of ROUTINE respiration [<xref ref-type="bibr" rid="B24-biomolecules-05-01319">24</xref>], suggesting that AmR concentrations and exposure time should be limited. The inhibitory effect depends on the medium used. Since the sensitivity of the AmR assay was rather low in DMEM, we applied Dulbecco&#x2019;s phosphate-buffered saline, in which case excellent assay sensitivity was associated with seriously compromised respiration, both with (up to 50% inhibition) and without AmR (up to 20% inhibition). A brief literature survey indicates that AmR concentrations and media applied are highly variable, ranging from 1 &#xB5;M AmR in PBS for the study of permeabilized C2C12 myoblasts and myotubes [<xref ref-type="bibr" rid="B25-biomolecules-05-01319">25</xref>], 10 &#xB5;M AmR in MiR05 for primary human skeletal myotubes [<xref ref-type="bibr" rid="B26-biomolecules-05-01319">26</xref>], to 50 &#xB5;M AmR in various phosphate-buffered or bicarbonate-buffered saline media investigating N27 cells [<xref ref-type="bibr" rid="B27-biomolecules-05-01319">27</xref>], A549 lung epithelial cells [<xref ref-type="bibr" rid="B20-biomolecules-05-01319">20</xref>], HaCaT keratinocytes [<xref ref-type="bibr" rid="B28-biomolecules-05-01319">28</xref>], or HEK 293T cells [<xref ref-type="bibr" rid="B29-biomolecules-05-01319">29</xref>], or mitochondria prepared from H9c2 rat cardiac myocytes [<xref ref-type="bibr" rid="B29-biomolecules-05-01319">29</xref>] or from HepG2 cells [<xref ref-type="bibr" rid="B30-biomolecules-05-01319">30</xref>]. In the absence of adequate controls it is not clear to which extent these treatments might have affected the results on H<sub>2</sub>O<sub>2</sub> production. Therefore, careful optimization is required both with regard to AmR concentrations and the incubation media for quality control of measurements on H<sub>2</sub>O<sub>2</sub> production in cells.</p>
        <p>Experiments with permeabilized cells were performed in MiR05 [<xref ref-type="bibr" rid="B31-biomolecules-05-01319">31</xref>] and AmR was titrated in the CI&amp;II-linked OXPHOS state, <italic>i.e.</italic>, in the presence of pyruvate, malate and succinate at saturating concentration of ADP (<xref ref-type="fig" rid="biomolecules-05-01319-f002">Figure 2</xref>). Respiration in controls was not affected by the carrier DMSO. In contrast, AmR inhibited CI&amp;II-linked OXPHOS capacity in a dose-dependent manner, resulting in 15% &#xB1; 7% inhibition at 30 &#xB5;M (mean &#xB1; SD, <italic>N</italic> = 5). Similarly, CI&amp;II-linked ETS capacity was reduced by 19% &#xB1; 8%, with a shift to a lower optimum uncoupler concentration compared to controls. CII-linked ETS capacity was not affected, possibly indicating that AmR inhibition occurred at CI, which is highly sensitive to agents damaging mitochondria [<xref ref-type="bibr" rid="B22-biomolecules-05-01319">22</xref>,<xref ref-type="bibr" rid="B32-biomolecules-05-01319">32</xref>,<xref ref-type="bibr" rid="B33-biomolecules-05-01319">33</xref>]. In order to minimize such side effects, the AmR concentration was reduced to 10 &#xB5;M for experiments with permeabilized cells.</p>
      </sec>
      <sec>
        <title>2.2. O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub> Flow in Permeabilized HEK 293T Cells: Dependence on Substrate and Coupling State</title>
        <p>O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub> fluxes were determined in permeabilized HEK 293T cells in a sequence of respiratory substrate and coupling states using pyruvate&amp;malate (PM; CI), pyruvate&amp;malate&amp;succinate (PMS; CI&amp;II) or succinate with Rot (S(Rot)) as respiratory substrates (<xref ref-type="fig" rid="biomolecules-05-01319-f003">Figure 3</xref>). Results are summarized in <xref ref-type="fig" rid="biomolecules-05-01319-f004">Figure 4</xref> and <xref ref-type="table" rid="biomolecules-05-01319-t002">Table 2</xref>. The H<sub>2</sub>O<sub>2</sub>/O flux ratio is frequently applied to evaluate the relative importance of H<sub>2</sub>O<sub>2</sub> production at different respiratory states [<xref ref-type="bibr" rid="B34-biomolecules-05-01319">34</xref>,<xref ref-type="bibr" rid="B35-biomolecules-05-01319">35</xref>].</p>
        <p>After permeabilization of the cell membranes with digitonin, addition of PM as substrates supporting CI-linked LEAK respiration (CI<italic><sub>L</sub></italic>) induced a moderate increase in respiration (<xref ref-type="fig" rid="biomolecules-05-01319-f003">Figure 3</xref>A). ADP added at a saturating concentration stimulated respiration about 5 times (CI-linked OXPHOS capacity, CI<italic><sub>P</sub></italic>). Succinate induced convergent CI&amp;II-linked OXPHOS (CI&amp;II<italic><sub>P</sub></italic>), at a 2.2-fold higher level compared to CI<italic><sub>P</sub></italic>. CCCP at optimum concentration elevated respiration further, showing a significant apparent excess ETS capacity in these cells. Subsequently Rot and Ama were added to obtain ROX. Despite these dramatic differences in oxygen fluxes in different respiratory states, alteration in H<sub>2</sub>O<sub>2</sub> fluxes were comparatively small. When total observed H<sub>2</sub>O<sub>2</sub> flux was corrected for the background chemical flux obtained in the absence of cells, the net fluxes were negative. This may indicate the ROS scavenging capacity introduced with the cells, as will be discussed below. Thus, even the most pronounced relative change in H<sub>2</sub>O<sub>2</sub> flux induced by inhibition of CIII (Ama) after ETS was close to the chemical background. As an alternative approach, the lowest flux detected in each experimental run was subtracted from H<sub>2</sub>O<sub>2</sub> flux in each respiratory state, expressing H<sub>2</sub>O<sub>2</sub> flux not as an absolute metabolic flux but as a difference, &#x394;H<sub>2</sub>O<sub>2</sub> flux (<xref ref-type="fig" rid="biomolecules-05-01319-f004">Figure 4</xref>C). The lowest H<sub>2</sub>O<sub>2</sub> flux was observed in fully uncoupled cells in almost all cases.</p>
        <fig id="biomolecules-05-01319-f003" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Combined determination of oxygen consumption and H<sub>2</sub>O<sub>2</sub> flux by O2k-Fluorometry in permeabilized HEK 293T cells. (<bold>A</bold>) Respiration and fluorescence changes using P and M as initial substrates; (<bold>B</bold>) Respiration and fluorescence changes using succinate (S) as initial substrate. Respirometric measurements are shown in the upper panels as described in <xref ref-type="fig" rid="biomolecules-05-01319-f001">Figure 1</xref>. U1 and U5 indicate final uncoupler concentrations [&#xB5;M] added in 1 &#xB5;M steps. In the lower panels the black plots show the fluorescence signal. H<sub>2</sub>O<sub>2</sub>* indicates titrations of 0.1 &#xB5;M H<sub>2</sub>O<sub>2</sub> for calibration, to convert the fluorescence signal to an equivalent H<sub>2</sub>O<sub>2</sub> concentration (left <italic>Y</italic>-axis [&#xB5;M]). Plots are shown on the basis of the first calibration with H<sub>2</sub>O<sub>2</sub>. The positive time derivative yields the volume-specific H<sub>2</sub>O<sub>2</sub> flux shown as the green plots (right <italic>Y</italic>-axis [pmol&#xB7;s<sup>&#x2212;1</sup>&#xB7;mL<sup>&#x2212;1</sup>]).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biomolecules-05-01319-g003.tif"/>
        </fig>
        <fig id="biomolecules-05-01319-f004" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Respiration and H<sub>2</sub>O<sub>2</sub> flow in permeabilized HEK 293T cells in SUIT protocols using PM (black bars), S (white bars) and S(Rot) (grey bars) as initial substrates. (<bold>A</bold>) Oxygen flow; (<bold>B</bold>) H<sub>2</sub>O<sub>2</sub> flow corrected for the background slope determined in the absence of cells; (<bold>C</bold>) H<sub>2</sub>O<sub>2</sub> flow corrected for the lowest observed slope. The fluorescence signals were calibrated using the H<sub>2</sub>O<sub>2</sub> titrations at the corresponding state (<xref ref-type="fig" rid="biomolecules-05-01319-f003">Figure 3</xref>). Bars are means &#xB1; SD of four independent cultures measured in duplicates.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biomolecules-05-01319-g004.tif"/>
        </fig>
        <table-wrap id="biomolecules-05-01319-t002" position="float">
          <object-id pub-id-type="pii">biomolecules-05-01319-t002_Table 2</object-id>
          <label>Table 2</label>
          <caption>
            <p>H<sub>2</sub>O<sub>2</sub>/O flux ratios [%] as a function of coupling and substrate states in permeabilized HEK cells and mouse brain homogenate.</p>
          </caption>
          <table>
            <thead>
              <tr>
                <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">Substrate</th>
                <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">LEAK</th>
                <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">OXPHOS</th>
                <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">PMS OXPHOS</th>
                <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">PMS ETS</th>
                <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">ROX</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center" valign="middle"> </td>
                <td colspan="5" align="center" valign="middle">
                  <bold>Permeabilized HEK cells</bold>
                </td>
              </tr>
              <tr>
                <td align="center" valign="middle" style="border-top:solid thin">S</td>
                <td align="center" valign="middle" style="border-top:solid thin">0.85 &#xB1; 0.34</td>
                <td align="center" valign="middle" style="border-top:solid thin">0.03 &#xB1; 0.08</td>
                <td align="center" valign="middle" style="border-top:solid thin">na</td>
                <td align="center" valign="middle" style="border-top:solid thin">na</td>
                <td align="center" valign="middle" style="border-top:solid thin">7.2 &#xB1; 22.8</td>
              </tr>
              <tr>
                <td align="center" valign="middle" style="border-bottom:solid thin">S(Rot)</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">0.81 &#xB1; 0.55</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">0.14 &#xB1; 0.07</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">0.16 &#xB1; 0.07</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">0.10 &#xB1; 0.7</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">7.9 &#xB1; 3.4</td>
              </tr>
              <tr>
                <td align="center" valign="middle"> </td>
                <td colspan="5" align="center" valign="middle">
                  <bold>Mouse brain homogenate</bold>
                </td>
              </tr>
              <tr>
                <td align="center" valign="middle" style="border-top:solid thin">PM</td>
                <td align="center" valign="middle" style="border-top:solid thin">1.2 &#xB1; 0.6</td>
                <td align="center" valign="middle" style="border-top:solid thin">0.06 &#xB1; 0.13</td>
                <td align="center" valign="middle" style="border-top:solid thin">na</td>
                <td align="center" valign="middle" style="border-top:solid thin">na</td>
                <td align="center" valign="middle" style="border-top:solid thin">60 &#xB1; 13</td>
              </tr>
              <tr>
                <td align="center" valign="middle">S</td>
                <td align="center" valign="middle">6.3 &#xB1; 0.2</td>
                <td align="center" valign="middle">0.05 &#xB1; 0.13</td>
                <td align="center" valign="middle">0.05 &#xB1; 0.09</td>
                <td align="center" valign="middle">na</td>
                <td align="center" valign="middle">26 &#xB1; 6</td>
              </tr>
              <tr>
                <td align="center" valign="middle" style="border-bottom:solid thin">S(Rot)</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">1.5 &#xB1; 0.2</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">0.51 &#xB1; 0.08</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">1.34 &#xB1; 0.09</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">1.24 &#xB1; 0.06</td>
                <td align="center" valign="middle" style="border-bottom:solid thin">33 &#xB1; 8</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>The H<sub>2</sub>O<sub>2</sub>/O flux ratio was calculated as H<sub>2</sub>O<sub>2</sub> flux/(0.5 O<sub>2</sub> flux). Means &#xB1; SD of 4 independent cultures or 3 animals. na&#x2014;not applicable.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>LEAK respiration supported by succinate (CII<italic><sub>L</sub></italic>) was about three times higher than <italic>L</italic> supported by PM (CI<italic><sub>L</sub></italic>) and was associated with much higher H<sub>2</sub>O<sub>2</sub> flux in the absence of rotenone. ADP induced a 6.7-fold increase in respiration (CII<italic><sub>P</sub></italic>) and a concurrent pronounced reduction in H<sub>2</sub>O<sub>2</sub> flux (<xref ref-type="fig" rid="biomolecules-05-01319-f003">Figure 3</xref>B). Surprisingly, addition of pyruvate did not stimulate respiration, and malate caused a slight inhibition, such that CI&amp;II<italic><sub>P</sub></italic> respiration was slightly reduced compared to CII<italic><sub>P</sub></italic>, whereas H<sub>2</sub>O<sub>2</sub> flux remained constant. The fact that rotenone was not required to obtain a high CII-linked OXPHOS capacity is consistent with a high malic enzyme activity in these cells [<xref ref-type="bibr" rid="B36-biomolecules-05-01319">36</xref>]. Thus, oxaloacetate does not accumulate to concentrations which inhibit succinate dehydrogenase, but pyruvate and further acetyl-CoA are formed from malate, supporting the utilization of oxaloacetate in the citrate synthase reaction [<xref ref-type="bibr" rid="B19-biomolecules-05-01319">19</xref>,<xref ref-type="bibr" rid="B37-biomolecules-05-01319">37</xref>]. Formation of NADH and its utilization by CI, therefore, proceeded in the CII-linked OXPHOS state, and CI&amp;II-linked and CII-linked OXPHOS capacities were not different (<xref ref-type="fig" rid="biomolecules-05-01319-f004">Figure 4</xref>). However, CI&amp;II<italic><sub>P</sub></italic> was limited by the capacity of the phosphorylation system, as shown by the increased ETS capacity with PMS (CI&amp;II<italic><sub>E</sub></italic>) which was higher than CII<italic><sub>E</sub></italic>, indicating the additive effect of convergent electron flow from CI&amp;II to the Q-junction in these cells [<xref ref-type="bibr" rid="B38-biomolecules-05-01319">38</xref>]. CCCP titration reduced the H<sub>2</sub>O<sub>2</sub> flux to a level slightly below baseline. As observed in the previous protocol, Ama induced an increase in H<sub>2</sub>O<sub>2</sub> flux (<xref ref-type="fig" rid="biomolecules-05-01319-f004">Figure 4</xref>).</p>
        <p>Respiration and H<sub>2</sub>O<sub>2</sub> flux in the LEAK state were similar with S(Rot) and S alone (<xref ref-type="fig" rid="biomolecules-05-01319-f004">Figure 4</xref>). In many other cells and tissues (e.g., rat brain homogenate as shown below), Rot causes a significant reduction of H<sub>2</sub>O<sub>2</sub> production observed in the CII-linked LEAK state due to inhibition of reversed electron flow to CI [<xref ref-type="bibr" rid="B39-biomolecules-05-01319">39</xref>]. The absence of such an effect is consistent with the effect of malic enzyme on respiration [<xref ref-type="bibr" rid="B19-biomolecules-05-01319">19</xref>]. In contrast to the presence of S alone, addition of ADP to S(Rot) exposed cells did not decrease the H<sub>2</sub>O<sub>2</sub> flux. The effects of PM and CCCP were relatively small, and the addition of Ama did not stimulate ROS production, in contrast to results obtained with the other protocols (<xref ref-type="fig" rid="biomolecules-05-01319-f004">Figure 4</xref>).</p>
        <p>Taken together, in permeabilized HEK 293T cells the highest H<sub>2</sub>O<sub>2</sub> flux was observed in the CII-linked LEAK state, amounting to about 0.8% of oxygen flux (<xref ref-type="table" rid="biomolecules-05-01319-t002">Table 2</xref>). In comparison, CI-linked H<sub>2</sub>O<sub>2</sub> flux appears negligible, while inhibition of CI increased H<sub>2</sub>O<sub>2</sub> production independent of respiratory state. H<sub>2</sub>O<sub>2</sub> flux in permeabilized HEK 293T cells was extremely low under the presently investigated conditions, accounting for less than 0.2% of O<sub>2</sub> flux in the OXPHOS and ETS states (<xref ref-type="table" rid="biomolecules-05-01319-t002">Table 2</xref>).</p>
      </sec>
      <sec>
        <title>2.3. O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub> Flow in Permeabilized HEK 293T Cells: Dependence on Cell Density</title>
        <p>Given that estimated H<sub>2</sub>O<sub>2</sub> fluxes were close to or even below background observed in the absence of cells, the sensitivity of the AmR assay may present a limiting factor at the experimental cell density. By increasing the cell density in the respiration chamber, however, the slopes of the fluorescence signal corrected for the background determined in the absence of cells actually displayed an inverse relation to cell density (<xref ref-type="fig" rid="biomolecules-05-01319-f005">Figure 5</xref>A). In contrast, when corrected for the slope observed in the presence of digitonin permeabilized cells without substrates added, net H<sub>2</sub>O<sub>2</sub> fluxes were largely independent of cell density (<xref ref-type="fig" rid="biomolecules-05-01319-f005">Figure 5</xref>B). Importantly, cell-specific respiration and net H<sub>2</sub>O<sub>2</sub> flow (per million cells) were independent of cell density (<xref ref-type="fig" rid="biomolecules-05-01319-f005">Figure 5</xref>C,D). A tentative explanation for these observations is that by increasing the number of cells in the chamber we also enhance the total ROS scavenging capacity associated with the cellular antioxidant systems. In addition, the optical properties are affected by cell density, as shown by the step change of the fluorescence signal upon injection of cells, and by the change of sensitivity when comparing calibrations before and after addition of cells, and after titration of digitonin. For example, sensitivity declined from 0.282 &#xB1; 0.019 V/&#xB5;M to 0.260 &#xB1; 0.019 V/&#xB5;M after addition of cells (<italic>n</italic> = 8 experiments), from 0.249 &#xB1; 0.033 V/&#xB5;M to 0.179 &#xB1; 0.018 V/&#xB5;M after adding brain tissue homogenate (<italic>n</italic> = 8 experiments), and from 0.262 V/&#xB5;M to 0.250 V/&#xB5;M after injection of mitochondria (means of two experiments). Whereas calibration of the fluorescence signal in the absence of cells is required to obtain the apparent background flux, H<sub>2</sub>O<sub>2</sub> calibrations are required in the presence of cells and under various respiratory states (<xref ref-type="fig" rid="biomolecules-05-01319-f003">Figure 3</xref>).</p>
        <fig id="biomolecules-05-01319-f005" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Effect of cell concentration in the O2k-chamber on H<sub>2</sub>O<sub>2</sub> flux and respiration of permeabilized HEK 293T cells. (<bold>A</bold>) H<sub>2</sub>O<sub>2</sub> flux (per O2k-chamber volume) corrected for the slope determined in the absence of cells; (<bold>B</bold>) H<sub>2</sub>O<sub>2</sub> flux (per O2k-chamber volume) corrected for the slope after addition of digitonin; (<bold>C</bold>) H<sub>2</sub>O<sub>2</sub> flow (per million cells) corrected for the slope after addition of digitonin; (<bold>D</bold>) Respiratory flow (per million cells). H<sub>2</sub>O<sub>2</sub> fluxes were calculated according to calibrations after addition of digitonin.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biomolecules-05-01319-g005.tif"/>
        </fig>
      </sec>
      <sec>
        <title>2.4. O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub> Flux in Mouse Brain Homogenate: Dependence on Substrate and Coupling State</title>
        <p><xref ref-type="fig" rid="biomolecules-05-01319-f006">Figure 6</xref> shows representative experiments of respiration and H<sub>2</sub>O<sub>2</sub> fluxes in mouse brain homogenate with identical SUIT protocols as applied with permeabilized HEK 293T cells (<xref ref-type="fig" rid="biomolecules-05-01319-f003">Figure 3</xref>). In contrast to permeabilized HEK 293T cells (<xref ref-type="fig" rid="biomolecules-05-01319-f004">Figure 4</xref>), CII<italic><sub>L</sub></italic> respiration was lower but CII<italic><sub>P</sub></italic> was higher with S(Rot) compared to S (<xref ref-type="fig" rid="biomolecules-05-01319-f007">Figure 7</xref>A). Addition of PM to S induced an increase of respiratory OXPHOS capacity (CI&amp;II<italic><sub>P</sub></italic>), despite of the inhibitory effect of malate (<xref ref-type="fig" rid="biomolecules-05-01319-f006">Figure 6</xref>B). Consistent with results in permeabilized cells, malate caused a significant decrease of CII<italic><sub>P</sub></italic> respiration with S(Rot) (<xref ref-type="fig" rid="biomolecules-05-01319-f006">Figure 6</xref>C). The inhibitory effect of malate on CII-linked respiration is a general feature of TCA cycle control [<xref ref-type="bibr" rid="B40-biomolecules-05-01319">40</xref>].</p>
        <p>In contrast to results with permeabilized cells, H<sub>2</sub>O<sub>2</sub> flux in state CI<italic><sub>L</sub></italic> was well above background in brain homogenate (<xref ref-type="fig" rid="biomolecules-05-01319-f006">Figure 6</xref>A). As in permeabilized HEK 293T cells, the highest H<sub>2</sub>O<sub>2</sub> flux was observed in the LEAK state with S alone (<xref ref-type="fig" rid="biomolecules-05-01319-f006">Figure 6</xref>B), and H<sub>2</sub>O<sub>2</sub> flux was significantly reduced in the OXPHOS and ETS state compared to LEAK (<xref ref-type="fig" rid="biomolecules-05-01319-f007">Figure 7</xref>B). However, addition of Rot caused a significant reduction of H<sub>2</sub>O<sub>2</sub> flux, as did addition of ADP (<xref ref-type="fig" rid="biomolecules-05-01319-f007">Figure 7</xref>B). Compared to CI<italic><sub>L</sub></italic>, H<sub>2</sub>O<sub>2</sub> flux in CII(Rot)<italic><sub>L</sub></italic> was 2.5 times higher (<xref ref-type="fig" rid="biomolecules-05-01319-f007">Figure 7</xref>B). No significant difference in H<sub>2</sub>O<sub>2</sub> flux was noted between LEAK and OXPHOS states with S(Rot). Surprisingly, addition of PM in state CII(Rot)<italic><sub>P</sub></italic> caused an increase of H<sub>2</sub>O<sub>2</sub> flux, although Complex I was inhibited by rotenone (<xref ref-type="fig" rid="biomolecules-05-01319-f006">Figure 6</xref>A and <xref ref-type="fig" rid="biomolecules-05-01319-f007">Figure 7</xref>B). As expected [<xref ref-type="bibr" rid="B41-biomolecules-05-01319">41</xref>], inhibition of CIII by Ama (ROX state) caused an increase in H<sub>2</sub>O<sub>2</sub> flux in all SUIT protocols (<xref ref-type="fig" rid="biomolecules-05-01319-f006">Figure 6</xref> and <xref ref-type="fig" rid="biomolecules-05-01319-f007">Figure 7</xref>B). H<sub>2</sub>O<sub>2</sub> flux resulted in similar patterns when corrected for background without homogenate (<xref ref-type="fig" rid="biomolecules-05-01319-f007">Figure 7</xref>B) or when presented as the difference of flux after subtraction of the minimal observed slope (<xref ref-type="fig" rid="biomolecules-05-01319-f007">Figure 7</xref>C).</p>
        <fig id="biomolecules-05-01319-f006" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Combined determination of oxygen consumption and H<sub>2</sub>O<sub>2</sub> flux by O2k-Fluorometry in mouse brain homogenate, using PM (<bold>A</bold>); S (<bold>B</bold>); or S(Rot) as initial substrate (<bold>C</bold>). For details see legend of <xref ref-type="fig" rid="biomolecules-05-01319-f003">Figure 3</xref>. Carrier denotes ethanol (1 &#xB5;L), which served as the solvent for rotenone and was titrated in parallel to rotenone.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biomolecules-05-01319-g006a.tif"/>
		  <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biomolecules-05-01319-g006b.tif"/>
        </fig>
        <p>The extraordinarily high H<sub>2</sub>O<sub>2</sub>/O flux ratio of 6% in CII<italic><sub>L</sub></italic> without Rot reflects maximal reversed electron transfer under an artificial substrate condition (<xref ref-type="table" rid="biomolecules-05-01319-t002">Table 2</xref>). H<sub>2</sub>O<sub>2</sub>/O flux ratios between 0.05% and 1.35% in OXPHOS and ETS states (<xref ref-type="table" rid="biomolecules-05-01319-t002">Table 2</xref>) are consistent with values reported for isolated mitochondria [<xref ref-type="bibr" rid="B1-biomolecules-05-01319">1</xref>,<xref ref-type="bibr" rid="B11-biomolecules-05-01319">11</xref>,<xref ref-type="bibr" rid="B42-biomolecules-05-01319">42</xref>]. It is thought that isolation procedures may impact on mitochondrial function (e.g., [<xref ref-type="bibr" rid="B43-biomolecules-05-01319">43</xref>,<xref ref-type="bibr" rid="B44-biomolecules-05-01319">44</xref>]). Isolated mitochondrial preparations may represent a selection for particular mitochondrial subpopulations. This is not the case in tissue homogenate or permeabilized tissue preparations. Tissue homogenization can be achieved without injury of the outer mitochondrial membrane using specifically dedicated instruments such as the PBI tissue shredder [<xref ref-type="bibr" rid="B45-biomolecules-05-01319">45</xref>,<xref ref-type="bibr" rid="B46-biomolecules-05-01319">46</xref>]. A more simple glass Potter homogenizer can be used similarly for homogenate preparation of soft tissues.</p>
        <p>Few comparable data are published on permeabilized cells. From data by Kwak <italic>et al.</italic> [<xref ref-type="bibr" rid="B26-biomolecules-05-01319">26</xref>] on permeabilized human skeletal myotubes it can be calculated that about 0.9% of LEAK respiration measured in the presence of a complex substrate mixture was diverted towards H<sub>2</sub>O<sub>2</sub> production, in close agreement with our result on 0.8% for HEK 293T cells in the presence of succinate (<xref ref-type="table" rid="biomolecules-05-01319-t002">Table 2</xref>). In permeabilized yeast cells the H<sub>2</sub>O<sub>2</sub>/O ratio varied between 0.25% and 2% depending on the glucose level supplied and the growth phase investigated [<xref ref-type="bibr" rid="B47-biomolecules-05-01319">47</xref>]. The H<sub>2</sub>O<sub>2</sub>/O flux ratio determined in a mutant <italic>E. coli</italic> strain was 0.35% to 0.6% in different substrate regimes [<xref ref-type="bibr" rid="B48-biomolecules-05-01319">48</xref>].</p>
        <fig id="biomolecules-05-01319-f007" position="float">
          <label>Figure 7</label>
          <caption>
            <p>Respiration and H<sub>2</sub>O<sub>2</sub> flux in mouse brain homogenate in SUIT protocols using PM (black bars), S (white bars) and S(Rot) (grey bars) as initial substrates. (<bold>A</bold>) Oxygen flux. (<bold>B</bold>) H<sub>2</sub>O<sub>2</sub> flux corrected for the slope determined in the absence of homogenate; (<bold>C</bold>) H<sub>2</sub>O<sub>2</sub> flux corrected for minimal observed slope. The fluorescence signals were calibrated using the H<sub>2</sub>O<sub>2</sub> titrations at the corresponding state (<xref ref-type="fig" rid="biomolecules-05-01319-f006">Figure 6</xref>). Bars are means &#xB1; SD of 3 animals, each measured in duplicate.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biomolecules-05-01319-g007.tif"/>
        </fig>
      </sec>
      <sec>
        <title>2.5. O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub> Flux in Isolated Cardiac Mitochondria: Dependence on Substrate and Coupling State</title>
        <p>Since the most pronounced changes of H<sub>2</sub>O<sub>2</sub> flux in permeabilized cells and brain homogenate were observed in protocols using S and S(Rot), we performed additional experiments applying CII-linked protocols with mitochondria isolated from mouse hearts. Like in mouse brain homogenate, the H<sub>2</sub>O<sub>2</sub> flux was extremely high in the succinate-supported LEAK state in the absence of Rot, resulting in a H<sub>2</sub>O<sub>2</sub>/O flux ratio of nearly 10%, compared to 1.5% in the presence of Rot (<xref ref-type="fig" rid="biomolecules-05-01319-f008">Figure 8</xref>). The addition of ADP to S(Rot) stimulated respiration and concurrently reduced H<sub>2</sub>O<sub>2</sub> flux (<xref ref-type="fig" rid="biomolecules-05-01319-f008">Figure 8</xref>B). In contrast, addition of ADP to S did not increase respiration, but dramatically diminished H<sub>2</sub>O<sub>2</sub> flux (<xref ref-type="fig" rid="biomolecules-05-01319-f008">Figure 8</xref>A). The subsequent addition of P caused a pronounced increase of respiratory OXPHOS capacity, by removing the inhibitory oxaloacetate and restoring CI&amp;II-linked TCA cycle activity [<xref ref-type="bibr" rid="B19-biomolecules-05-01319">19</xref>]. Malate exerted an inhibitory effect in the presence and absence of Rot, similar to results with brain homogenate (<xref ref-type="fig" rid="biomolecules-05-01319-f006">Figure 6</xref>B,C). Uncoupler did not stimulate respiration beyond OXPHOS capacity, indicating that there is no apparent ETS excess capacity in mouse heart in contrast to mouse brain mitochondria. H<sub>2</sub>O<sub>2</sub> fluxes were slightly elevated by P in both protocols, largely unresponsive to M, and slightly diminished by uncoupler, while Rot and Ama caused a substantial increase of H<sub>2</sub>O<sub>2</sub> flux (<xref ref-type="fig" rid="biomolecules-05-01319-f008">Figure 8</xref>A,B). H<sub>2</sub>O<sub>2</sub>/O flux ratios ranged from 0.04% in ETS in the absence of Rot to 0.9% in OXPHOS and ETS in the presence of Rot, consistent with data reported in the literature [<xref ref-type="bibr" rid="B5-biomolecules-05-01319">5</xref>,<xref ref-type="bibr" rid="B49-biomolecules-05-01319">49</xref>].</p>
        <fig id="biomolecules-05-01319-f008" position="float">
          <label>Figure 8</label>
          <caption>
            <p>Combined determination of oxygen consumption and H<sub>2</sub>O<sub>2</sub> production by O2k-Fluorometry in mouse isolated cardiac mitochondria, using S (<bold>A</bold>); or S(Rot) (<bold>B</bold>) as initial substrate. For details see legend of <xref ref-type="fig" rid="biomolecules-05-01319-f003">Figure 3</xref>.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biomolecules-05-01319-g008.tif"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>3. Experimental Section</title>
      <sec>
        <title>3.1. Chemicals</title>
        <p>Dulbecco&#x2019;s modified eagle medium (DMEM-low glucose, with <sc>l</sc>-glutamine) was from PAA Laboratories GmbH, Pasching, Austria, fetal bovine serum from Biowest, Nuaill&#xE9;, France, and penicillin and streptomycin stocks were from Gibco, Vienna, Austria.</p>
        <p>Amplex<sup>&#xAE;</sup> UltraRed was obtained from Life Technologies. H<sub>2</sub>O<sub>2</sub>, HRP, SOD, substrates, inhibitors and other chemicals were from Sigma-Aldrich, Acros Organics or Invitrogen [<xref ref-type="bibr" rid="B50-biomolecules-05-01319">50</xref>].</p>
      </sec>
      <sec>
        <title>3.2. High-Resolution Respirometry and O2k-Fluorometry</title>
        <p>The Oxygraph-2k (O2k, OROBOROS Instruments, Innsbruck, Austria) was used for measurements of respiration [<xref ref-type="bibr" rid="B50-biomolecules-05-01319">50</xref>] and combined with the Fluorescence-Sensor Green of the O2k-Fluo LED2-Module for H<sub>2</sub>O<sub>2</sub> measurement. Up to four O2k instruments (eight chambers) were used in parallel. Experiments using tissue homogenate and permeabilized cells were performed in MiR05 (110 mM sucrose, 60 mM K-lactobionate, 0.5 mM EGTA, 3 mM MgCl<sub>2</sub>, 20 mM taurine, 10 mM KH<sub>2</sub>PO<sub>4</sub>, 20 mM HEPES, pH 7.1 at 30 &#xB0;C, and 0.1% BSA essentially fatty acid free; [<xref ref-type="bibr" rid="B31-biomolecules-05-01319">31</xref>]). Dulbecco&#x2019;s modified eagle medium supplemented with 10% fetal bovine serum and 50 units/mL penicillin and 50 &#x3BC;g/mL streptomycin was used for measurements on intact cells. All experiments were performed at 37 &#xB0;C. The medium was reoxygenated when oxygen concentrations reached 80 &#xB5;M unless otherwise indicated.</p>
      </sec>
      <sec>
        <title>3.3. Experimental Procedure</title>
        <p>Respiration of permeabilized cells and tissue homogenate was determined using substrate-uncoupler-inhibitor titration (SUIT) protocols [<xref ref-type="bibr" rid="B50-biomolecules-05-01319">50</xref>] with modifications. Pyruvate and malate (5 mM and 0.5 mM, respectively) or succinate (10 mM) with or without 0.5 &#xB5;M Complex I inhibitor rotenone (Rot) were used to determine Complex I (CI) or Complex II (CII) linked LEAK respiration. ADP was added at 2.5 mM final concentration, which was saturating for oxygen flux to obtain OXPHOS capacity. Additional substrates were added sequentially to reconstitute convergent CI&amp;II-linked respiration. Titrations with the uncoupler CCCP (0.5&#x2013;1 &#xB5;M steps) were performed to determine electron transfer system (ETS) capacity. Rot, if not already present, and Ama (2.5 &#xB5;M to inhibit Complex III) were added for determination of residual oxygen consumption (ROX).</p>
        <p>Respiration of intact cells was measured applying a coupling control protocol [<xref ref-type="bibr" rid="B19-biomolecules-05-01319">19</xref>]. Up to 300 &#xB5;L of suspended cells were added to the respiration medium. After stabilization of ROUTINE respiration, the ATP-synthase inhibitor oligomycin (Omy, 2 &#xB5;g/mL) was added to obtain a measure of LEAK respiration, followed by titration of CCCP to maximum oxygen flux (ETS capacity). Finally, Rot and Ama were added to obtain ROX.</p>
        <p>H<sub>2</sub>O<sub>2</sub> flux was measured simultaneously with respirometry in the O2k-Fluorometer using the H<sub>2</sub>O<sub>2</sub>-sensitive probe Amplex&#xAE; UltraRed [<xref ref-type="bibr" rid="B15-biomolecules-05-01319">15</xref>]. 10 &#xB5;M Amplex&#xAE; UltraRed (AmR), 1 U/mL horse radish peroxidase (HRP) and 5 U/mL superoxide dismutase (SOD) were added to the chamber. The reaction product between AmR and H<sub>2</sub>O<sub>2</sub>, catalyzed by HRP, is fluorescent, similar to resorufin. Calibrations were performed with H<sub>2</sub>O<sub>2</sub> repeatedly added at 0.1 &#xB5;M steps as indicated (H<sub>2</sub>O<sub>2</sub>*). Volume-specific H<sub>2</sub>O<sub>2</sub> fluxes were calculated real-time by the DatLab software (OROBOROS INSTRUMENTS, Innsbruck, Austria) from the positive time derivative of the resorufin signal over time (converted to H<sub>2</sub>O<sub>2</sub> concentration based on the calibrations with H<sub>2</sub>O<sub>2</sub>). Only the stable portions of the apparent fluxes were selected and artifacts induced by additions of chemicals or re-oxygenations were excluded.</p>
      </sec>
      <sec>
        <title>3.4. Cell Culture</title>
        <p>Human embryonic kidney cells (HEK 293T, ATCC collection code CRL-1573) were cultured in 10 cm<sup>2</sup> culture dishes in DMEM high glucose medium supplemented with additions as indicated above until approximately 90% confluence was reached. Immediately prior to respirometric assays the cells were washed with PBS, trypsinized and resuspended in MiR05 or DMEM. The final concentration of permeabilized cells in the O2k-chamber was 1.75&#xB7;10<sup>6</sup>/mL or 1.5&#x2013;2&#xB7;10<sup>6</sup>/mL when intact cells were examined. Cells were permeabilized after addition to the respirometer chambers using digitonin at a final concentration of 10 &#xB5;g/mL. This concentration was evaluated in preliminary experiments to achieve full permeabilization of cells to allow for uninhibited access of substrates and ADP to mitochondria without compromising mitochondrial function [<xref ref-type="bibr" rid="B50-biomolecules-05-01319">50</xref>].</p>
      </sec>
      <sec>
        <title>3.5. Preparation of Mouse Brain Homogenate</title>
        <p>Wild-type C57BL/6 mice (age 2&#x2013;3 months) were housed under standard conditions (21&#x2013;23 &#xB0;C, 12 h light/dark cycle, relative humidity 45%&#x2013;65%) with unlimited access to food and water. The experimental procedures were performed in accordance with the guidelines of the European Community as well as local laws and policies.</p>
        <p>Animals were sacrificed by cervical dislocation, the skull opened with scissors and the brain removed. Brain cortex was dissected and washed in ice-cold MiR05Cr (MiR05 supplemented with 20 mM creatine). The tissue was transferred to a pre-cooled glass Potter homogenizer and homogenized with 10&#x2013;15 strokes at medium speed. The resulting homogenate was then kept on ice and used for respirometry without further processing. The final concentration of tissue in the O2k-chamber was 1 mg/mL.</p>
      </sec>
      <sec>
        <title>3.6. Isolation of Mouse Heart Mitochondria</title>
        <p>Wild-type C57BL/6 mice were sacrificed by cervical dislocation and the heart was excised and weighed. The heart was washed in ice-cold BIOPS and minced in 1 mL of BIOPS. The tissue was transferred to a pre-cooled glass Potter homogenizer with 2 mL of isolation buffer (225 mM mannitol, 75 mM sucrose, 1 mM EGTA, 2.5 mg/mL BSA) supplemented with Subtilisin (0.5 mg/mL). The tissue was homogenized with 6&#x2013;8 strokes at medium speed. The resulting homogenate was centrifuged for 10 min at 800&#xD7; <italic>g</italic>, 4 &#xB0;C. Then, the supernatant was transferred to a new tube and centrifuged for 10 min at 10,000&#xD7; <italic>g</italic>, 4 &#xB0;C. After centrifugation, the supernatant was carefully discarded, the mitochondrial pellet was washed in 2 mL isolation buffer and resuspended in 100 &#xB5;L of isolation buffer. Isolated heart mitochondria were stored on ice until use. 5 &#xB5;L of mitochondrial suspension per chamber were used for each measurement.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>4. Conclusions</title>
      <p>SUIT protocols allow a detailed analysis of mitochondrial fitness in permeabilized tissues and cells, tissue homogenates and isolated mitochondria, extended by combining OXPHOS analysis with measurement of hydrogen peroxide production. Combined measurements provide the basis for quality control to avoid experimental artifacts. AmR inhibited respiration of intact and permeabilized cells and should not be applied at concentrations above 10 &#xB5;M nor during prolonged exposure. The choice of experimental medium is critical and simple media may aggravate the inhibitory effect of AmR. Inhibition of respiration (e.g., by Rot and Ama) exerts an influence on H<sub>2</sub>O<sub>2</sub> production which is not generally predictable. When increasing the cell density, the cellular ROS scavenging capacity is increased together with the total H<sub>2</sub>O<sub>2</sub> production, which provides the explanation for our observation that volume-specific H<sub>2</sub>O<sub>2</sub> production remained constant or even declined with increasing cell density. H<sub>2</sub>O<sub>2</sub> fluxes were generally less than 1% of oxygen fluxes in physiological substrate and coupling states. In permeabilized cells only net rates are obtained on H<sub>2</sub>O<sub>2</sub> production escaping the cellular scavenging systems.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>Supported in part by the Tyrolean Government and the European Regional Development Fund (ERDF; K-Regio project; MitoFit; Erich Gnaiger).</p>
      <p>Marina Makrecka-Kuka was supported by a travel grant from 7th Framework Programme project InnovaBalt. We thank Mona Fontana-Ayoub for expert technical support.</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>Designed the experiments: Marina Makrecka-Kuka, Gerhard Krumschnabel, and Erich Gnaiger. Performed the experiments: Marina Makrecka-Kuka and Gerhard Krumschnabel. Analyzed the experiments: Marina Makrecka-Kuka, Gerhard Krumschnabel, and Erich Gnaiger. Wrote the paper: Marina Makrecka-Kuka, Gerhard Krumschnabel, and Erich Gnaiger.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>Gerhard Krumschnabel and Erich Gnaiger are affiliated with OROBOROS INSTRUMENTS.</p>
    </notes>
	<glossary>
    <title>Abbreviations (See also <xref ref-type="table" rid="biomolecules-05-01319-t001">Table 1</xref>)</title>
     <gloss-group>
	 <array>
 <tbody>
    <tr><td>Ama</td>
        <td>Antimycin A</td>
        <td>Rot</td>
        <td>rotenone</td></tr>
    <tr><td>AmR</td>
        <td>Amplex UltraRed</td>
        <td>ROX</td>
        <td>residual oxygen consumption</td></tr>
    <tr><td>Dig</td>
        <td>digitonin</td>
        <td>S</td>
        <td>succinate</td></tr>
    <tr><td>G</td>
        <td>glutamate</td>
        <td>SOD</td>
        <td>superoxide dismutase</td></tr>
	<tr><td>HRP</td>
        <td>horse radish peroxidase</td>
        <td>SUIT</td>
        <td>substrate-uncoupler-inhibitor titration</td></tr>
    <tr><td>M</td>
        <td>malate</td>
        <td>Thom</td>
        <td>tissue homogenate</td></tr>
	<tr><td>P</td>
        <td>pyruvate</td>
        <td>U</td>
        <td>uncoupler</td></tr>		
 </tbody>
</array>
      </gloss-group>
    </glossary>
    <ref-list>
      <title>References</title>
      <ref id="B1-biomolecules-05-01319">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sena</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Chandel</surname>
              <given-names>N.S.</given-names>
            </name>
          </person-group>
          <article-title>Physiological roles of mitochondrial reactive oxygen species</article-title>
          <source>Mol. Cell</source>
          <year>2012</year>
          <volume>48</volume>
          <fpage>158</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2012.09.025</pub-id>
          <pub-id pub-id-type="pmid">23102266</pub-id>
        </citation>
      </ref>
      <ref id="B2-biomolecules-05-01319">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Szczepanek</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lesnefsky</surname>
              <given-names>E.J.</given-names>
            </name>
          </person-group>
          <article-title>A deficiency of apoptosis inducing factor (AIF) in Harlequin mouse heart mitochondria paradoxically reduces ROS generation during ischemia-reperfusion</article-title>
          <source>Front. Physiol.</source>
          <year>2014</year>
          <pub-id pub-id-type="doi">10.3389/fphys.2014.00271</pub-id>
          <pub-id pub-id-type="pmid">25101006</pub-id>
        </citation>
      </ref>
      <ref id="B3-biomolecules-05-01319">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dai</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Chiao</surname>
              <given-names>Y.A.</given-names>
            </name>
            <name>
              <surname>Marcinek</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Szeto</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Rabinovitch</surname>
              <given-names>P.S.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial oxidative stress in aging and healthspan</article-title>
          <source>Longev. Healthspan.</source>
          <year>2014</year>
          <pub-id pub-id-type="doi">10.1186/2046-2395-3-6</pub-id>
          <pub-id pub-id-type="pmid">24860647</pub-id>
        </citation>
      </ref>
      <ref id="B4-biomolecules-05-01319">
        <label>4.</label>
		 <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Lisa</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Kaludercic</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Carpi</surname>
              <given-names>A.</given-names>
            </name>
			 <name>
              <surname>Menab&#xF2;</surname>
              <given-names>R.</given-names>
            </name>
			 <name>
              <surname>Giorgio</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondria and vascular pathology</article-title>
          <source>Pharmacol. Rep.</source>
          <year>2009</year>
		  <volume>61</volume>
          <fpage>123</fpage>
          <lpage>130</lpage>
        </citation>
      </ref>
      <ref id="B5-biomolecules-05-01319">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tahara</surname>
              <given-names>E.B.</given-names>
            </name>
            <name>
              <surname>Navarete</surname>
              <given-names>F.D.</given-names>
            </name>
            <name>
              <surname>Kowaltowski</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation</article-title>
          <source>Free Radic. Biol. Med.</source>
          <year>2009</year>
          <volume>46</volume>
          <fpage>1283</fpage>
          <lpage>1297</lpage>
          <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.02.008</pub-id>
          <pub-id pub-id-type="pmid">19245829</pub-id>
        </citation>
      </ref>
      <ref id="B6-biomolecules-05-01319">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dr&#xF6;se</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanisms of superoxide production by the mitochondrial respiratory chain</article-title>
          <source>Adv. Exp. Med. Biol.</source>
          <year>2012</year>
          <volume>748</volume>
          <fpage>145</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="pmid">22729857</pub-id>
        </citation>
      </ref>
      <ref id="B7-biomolecules-05-01319">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suski</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Lebiedzinska</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bonora</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pinton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Duszynski</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wieckowski</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Relation between mitochondrial membrane potential and ROS formation</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2012</year>
          <volume>810</volume>
          <fpage>183</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="pmid">22057568</pub-id>
        </citation>
      </ref>
      <ref id="B8-biomolecules-05-01319">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Starkov</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>Measurement of mitochondrial ROS production</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2010</year>
          <volume>648</volume>
          <fpage>245</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="pmid">20700717</pub-id>
        </citation>
      </ref>
      <ref id="B9-biomolecules-05-01319">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kowaltowski</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>de Souza-Pinto</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Castilho</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Vercesi</surname>
              <given-names>A.E.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondria and reactive oxygen species</article-title>
          <source>Free Radic. Biol. Med.</source>
          <year>2009</year>
          <volume>47</volume>
          <fpage>333</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.05.004</pub-id>
          <pub-id pub-id-type="pmid">19427899</pub-id>
        </citation>
      </ref>
      <ref id="B10-biomolecules-05-01319">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>R.K.</given-names>
            </name>
          </person-group>
          <article-title>Uncoupling protein 1 dependent reactive oxygen species production by thymus mitochondria</article-title>
          <source>Int. J. Biochem. Cell Biol.</source>
          <year>2013</year>
          <volume>45</volume>
          <fpage>81</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biocel.2012.09.023</pub-id>
          <pub-id pub-id-type="pmid">23036787</pub-id>
        </citation>
      </ref>
      <ref id="B11-biomolecules-05-01319">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malinska</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kudin</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Debska-Vielhaber</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Vielhaber</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kunz</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Quantification of superoxide production by mouse brain and skeletal muscle mitochondria</article-title>
          <source>Methods Enzymol.</source>
          <year>2009</year>
          <volume>456</volume>
          <fpage>419</fpage>
          <lpage>437</lpage>
          <pub-id pub-id-type="pmid">19348902</pub-id>
        </citation>
      </ref>
      <ref id="B12-biomolecules-05-01319">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tretter</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Adam-Vizi</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>Uncoupling is without an effect on the production of reactive oxygen species by <italic>in situ</italic> synaptic mitochondria</article-title>
          <source>J. Neurochem.</source>
          <year>2007</year>
          <volume>103</volume>
          <fpage>1864</fpage>
          <lpage>1871</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04891.x</pub-id>
          <pub-id pub-id-type="pmid">17854347</pub-id>
        </citation>
      </ref>
      <ref id="B13-biomolecules-05-01319">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tretter</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Adam-Vizi</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>High Ca<sup>2+</sup> load promotes hydrogen peroxide generation via activation of &#x3B1;-glycerophosphate dehydrogenase in brain mitochondria</article-title>
          <source>Free Radic. Biol. Med.</source>
          <year>2012</year>
          <volume>53</volume>
          <fpage>2119</fpage>
          <lpage>2130</lpage>
          <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.09.029</pub-id>
          <pub-id pub-id-type="pmid">23022874</pub-id>
        </citation>
      </ref>
      <ref id="B14-biomolecules-05-01319">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tretter</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Takacs</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>K&#xF6;v&#xE9;r</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Adam-Vizi</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of H<sub>2</sub>O<sub>2</sub> generation by calcium in brain mitochondria respiring on alpha-glycerophosphate</article-title>
          <source>J. Neurosci. Res.</source>
          <year>2007</year>
          <volume>85</volume>
          <fpage>3471</fpage>
          <lpage>3479</lpage>
          <pub-id pub-id-type="doi">10.1002/jnr.21405</pub-id>
          <pub-id pub-id-type="pmid">17600838</pub-id>
        </citation>
      </ref>
      <ref id="B15-biomolecules-05-01319">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krumschnabel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Fontana-Ayoub</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sumbalova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Heidler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gauper</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fasching</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Simultaneous high-resolution measurement of mitochondrial respiration and hydrogen peroxide production</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2015</year>
          <volume>1264</volume>
          <fpage>245</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="pmid">25631019</pub-id>
        </citation>
      </ref>
      <ref id="B16-biomolecules-05-01319">
        <label>16.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Polarographic Oxygen Sensors, the Oxygraph and High-Resolution Respirometry to Assess Mitochondrial Function</article-title>
          <source>Mitochondrial Dysfunction in Drug-Induced Toxicity</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Dykens</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Will</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <publisher-name>John Wiley</publisher-name>
          <publisher-loc>Hoboken, NJ, USA</publisher-loc>
          <year>2008</year>
          <fpage>327</fpage>
          <lpage>352</lpage>
        </citation>
      </ref>
      <ref id="B17-biomolecules-05-01319">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Capacity of oxidative phosphorylation in human skeletal muscle. New perspectives of mitochondrial physiology</article-title>
          <source>Int. J. Biochem. Cell Biol.</source>
          <year>2009</year>
          <volume>41</volume>
          <fpage>1837</fpage>
          <lpage>1845</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biocel.2009.03.013</pub-id>
          <pub-id pub-id-type="pmid">19467914</pub-id>
        </citation>
      </ref>
      <ref id="B18-biomolecules-05-01319">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chance</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>G.R.</given-names>
            </name>
          </person-group>
          <article-title>Respiratory enzymes in oxidative phosphorylation: III. The steady state</article-title>
          <source>J. Biol. Chem.</source>
          <year>1955</year>
          <volume>217</volume>
          <fpage>409</fpage>
          <lpage>427</lpage>
          <pub-id pub-id-type="pmid">13271404</pub-id>
        </citation>
      </ref>
      <ref id="B19-biomolecules-05-01319">
        <label>19.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <source>Mitochondrial Pathways and Respiratory Control. An Introduction to OXPHOS Analysis</source>
          <edition>4th ed.</edition>
		  <comment>Mitochondr Physiol Network 19.12</comment>
          <publisher-name>OROBOROS MiPNet Publications</publisher-name>
          <publisher-loc>Innsbruck, Austria</publisher-loc>
          <year>2014</year>
          <fpage>80</fpage>
        </citation>
      </ref>
      <ref id="B20-biomolecules-05-01319">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kov&#xE1;cs</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Erd&#xE9;lyi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Heged&#x171;s</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lakatos</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Regdon</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hask&#xF3;</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Szab&#xF3;</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Vir&#xE1;g</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Poly(ADP-ribosyl)ation is a survival mechanism in cigarette smoke-induced and hydrogen peroxide-mediated cell death</article-title>
          <source>Free Radic. Biol. Med.</source>
          <year>2012</year>
          <volume>53</volume>
          <fpage>1680</fpage>
          <lpage>1688</lpage>
          <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.08.579</pub-id>
          <pub-id pub-id-type="pmid">22964577</pub-id>
        </citation>
      </ref>
      <ref id="B21-biomolecules-05-01319">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marchissio</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Franc&#xE9;s</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Carnovale</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Marinelli</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial aquaporin-8 knockdown in human hepatoma HepG2 cells causes ROS-induced mitochondrial depolarization and loss of viability</article-title>
          <source>Toxicol. Appl. Pharmacol.</source>
          <year>2012</year>
          <volume>264</volume>
          <fpage>246</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="doi">10.1016/j.taap.2012.08.005</pub-id>
          <pub-id pub-id-type="pmid">22910329</pub-id>
        </citation>
      </ref>
      <ref id="B22-biomolecules-05-01319">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krumschnabel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Eigentler</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fasching</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Use of safranin for the assessment of mitochondrial membrane potential by high-resolution respirometry and fluorometry</article-title>
          <source>Methods Enzymol.</source>
          <year>2014</year>
          <volume>542</volume>
          <fpage>163</fpage>
          <lpage>181</lpage>
          <pub-id pub-id-type="pmid">24862266</pub-id>
        </citation>
      </ref>
      <ref id="B23-biomolecules-05-01319">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scaduto</surname>
              <given-names>R.C.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Grotyohann</surname>
              <given-names>L.W.</given-names>
            </name>
          </person-group>
          <article-title>Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives</article-title>
          <source>Biophys. J.</source>
          <year>1999</year>
          <volume>76</volume>
          <fpage>469</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-3495(99)77214-0</pub-id>
        </citation>
      </ref>
      <ref id="B24-biomolecules-05-01319">
        <label>24.</label>
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Krumschnabel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Nydlova</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Vrbova</surname>
              <given-names>M.</given-names>
            </name>
          <aff>OROBOROS INSTRUMENTS, Innsbruck, Austria</aff>
          </person-group>
          <comment>Unpublished work</comment>
          <year>2015</year>
        </citation>
      </ref>
      <ref id="B25-biomolecules-05-01319">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wojtala</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bonora</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Malinska</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Pinton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Duszynski</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wieckowski</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Methods to monitor ROS production by fluorescence microscopy and fluorometry</article-title>
          <source>Methods Enzymol.</source>
          <year>2014</year>
          <volume>542</volume>
          <fpage>243</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="pmid">24862270</pub-id>
        </citation>
      </ref>
      <ref id="B26-biomolecules-05-01319">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kwak</surname>
              <given-names>H.B.</given-names>
            </name>
            <name>
              <surname>Thalacker-Mercer</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Cortright</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Bamman</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Neufer</surname>
              <given-names>P.D.</given-names>
            </name>
          </person-group>
          <article-title>Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes</article-title>
          <source>Free Radic. Biol. Med.</source>
          <year>2012</year>
          <volume>52</volume>
          <fpage>198</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.10.449</pub-id>
          <pub-id pub-id-type="pmid">22080086</pub-id>
        </citation>
      </ref>
      <ref id="B27-biomolecules-05-01319">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cantu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Fulton</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Drechsel</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial aconitase knockdown attenuates paraquat-induced dopaminergic cell death via decreased cellular metabolism and release of iron and H<sub>2</sub>O<sub>2</sub></article-title>
          <source>J. Neurochem.</source>
          <year>2011</year>
          <volume>118</volume>
          <fpage>79</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07290.x</pub-id>
          <pub-id pub-id-type="pmid">21517855</pub-id>
        </citation>
      </ref>
      <ref id="B28-biomolecules-05-01319">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Summers</surname>
              <given-names>F.A.</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>R.P.</given-names>
            </name>
          </person-group>
          <article-title>Photooxidation of Amplex Red to resorufin: Implications of exposing the Amplex Red assay to light</article-title>
          <source>Free Radic. Biol. Med.</source>
          <year>2012</year>
          <volume>53</volume>
          <fpage>1080</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.06.034</pub-id>
          <pub-id pub-id-type="pmid">22765927</pub-id>
        </citation>
      </ref>
      <ref id="B29-biomolecules-05-01319">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suhane</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kanzaki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Arumugaswami</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Murali</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Ramanujan</surname>
              <given-names>V.K.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial NDUFS3 regulates the ROS-mediated onset of metabolic switch in transformed cells</article-title>
          <source>Biol. Open.</source>
          <year>2013</year>
          <volume>2</volume>
          <fpage>295</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="doi">10.1242/bio.20133244</pub-id>
          <pub-id pub-id-type="pmid">23519235</pub-id>
        </citation>
      </ref>
      <ref id="B30-biomolecules-05-01319">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tak</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rashid</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Ha</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial H<sub>2</sub>O<sub>2</sub> generated from electron transport chain complex I stimulates muscle differentiation</article-title>
          <source>Cell Res.</source>
          <year>2011</year>
          <volume>21</volume>
          <fpage>817</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="doi">10.1038/cr.2011.55</pub-id>
          <pub-id pub-id-type="pmid">21445095</pub-id>
        </citation>
      </ref>
      <ref id="B31-biomolecules-05-01319">
        <label>31.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Kuznetsov</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Schneeberger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Seiler</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Brandacher</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Steurer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Margreiter</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondria in the Cold</article-title>
          <source>Life in the Cold</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Heldmaier</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Klingenspor</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <publisher-name>Springer</publisher-name>
          <publisher-loc>Heiderlberg, Germany</publisher-loc>
          <year>2000</year>
          <fpage>431</fpage>
          <lpage>442</lpage>
        </citation>
      </ref>
      <ref id="B32-biomolecules-05-01319">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borutaite</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Toleikis</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>G.C.</given-names>
            </name>
          </person-group>
          <article-title>In the eye of the storm: mitochondrial damage during heart and brain ischaemia</article-title>
          <source>FEBS J.</source>
          <year>2013</year>
          <volume>280</volume>
          <fpage>4999</fpage>
          <lpage>5014</lpage>
          <pub-id pub-id-type="doi">10.1111/febs.12353</pub-id>
          <pub-id pub-id-type="pmid">23710974</pub-id>
        </citation>
      </ref>
      <ref id="B33-biomolecules-05-01319">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fassone</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Complex I deficiency: Clinical features, biochemistry and molecular genetics</article-title>
          <source>J. Med. Genet.</source>
          <year>2012</year>
          <volume>49</volume>
          <fpage>578</fpage>
          <lpage>590</lpage>
          <pub-id pub-id-type="doi">10.1136/jmedgenet-2012-101159</pub-id>
          <pub-id pub-id-type="pmid">22972949</pub-id>
        </citation>
      </ref>
      <ref id="B34-biomolecules-05-01319">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffman</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Brookes</surname>
              <given-names>P.S.</given-names>
            </name>
          </person-group>
          <article-title>Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions</article-title>
          <source>J. Biol. Chem.</source>
          <year>2009</year>
          <volume>284</volume>
          <fpage>16236</fpage>
          <lpage>16245</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M809512200</pub-id>
          <pub-id pub-id-type="pmid">19366681</pub-id>
        </citation>
      </ref>
      <ref id="B35-biomolecules-05-01319">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pham</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Loiselle</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Power</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hickey</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart</article-title>
          <source>Am. J. Physiol. Cell Physiol.</source>
          <year>2014</year>
          <volume>307</volume>
          <fpage>C499</fpage>
          <lpage>C507</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpcell.00006.2014</pub-id>
          <pub-id pub-id-type="pmid">24920675</pub-id>
        </citation>
      </ref>
      <ref id="B36-biomolecules-05-01319">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henry</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Jolicoeur</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kamen</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Unraveling the metabolism of HEK-293 cells using lactate isotopomer analysis</article-title>
          <source>Bioprocess Biosyst. Eng.</source>
          <year>2011</year>
          <volume>34</volume>
          <fpage>263</fpage>
          <lpage>267</lpage>
          <pub-id pub-id-type="doi">10.1007/s00449-010-0468-9</pub-id>
          <pub-id pub-id-type="pmid">20848294</pub-id>
        </citation>
      </ref>
      <ref id="B37-biomolecules-05-01319">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sauer</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Dauchy</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Nagel</surname>
              <given-names>W.O.</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>H.P.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial malic enzymes. Mitochondrial NAD(P)<sup>+</sup>-dependent malic enzyme activity and malate-dependent pyruvate formation are progression-linked in Morris hepatomas</article-title>
          <source>J. Biol. Chem.</source>
          <year>1980</year>
          <volume>255</volume>
          <fpage>3844</fpage>
          <lpage>3848</lpage>
          <pub-id pub-id-type="pmid">7372652</pub-id>
        </citation>
      </ref>
      <ref id="B38-biomolecules-05-01319">
        <label>38.</label>
        <citation citation-type="web">
          <person-group person-group-type="author">
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>P/E from Mouse to Man</article-title>
          <comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://wiki.oroboros.at/index.php/OXPHOS_control_ratio#P.2FE_from_mouse_to_man" ext-link-type="uri">http://wiki.oroboros.at/index.php/OXPHOS_control_ratio#P.2FE_from_mouse_to_man</ext-link></comment>
          <access-date>(accessed on 5 June 2015)</access-date>
        </citation>
      </ref>
      <ref id="B39-biomolecules-05-01319">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loschen</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Flohe</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Chance</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Respiratory chain linked H<sub>2</sub>O<sub>2</sub> production in pigeon heart mitochondria</article-title>
          <source>FEBS Lett.</source>
          <year>1971</year>
          <volume>18</volume>
          <fpage>261</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="doi">10.1016/0014-5793(71)80459-3</pub-id>
        </citation>
      </ref>
      <ref id="B40-biomolecules-05-01319">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sumbalova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Vancova</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Krumschnabel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Optimization of malate concentration for high-resolution respirometry: Mitochondria from rat liver and brain</article-title>
          <source>Mitochondr. Physiol. Network</source>
          <year>2014</year>
          <volume>19.13</volume>
          <fpage>37</fpage>
        </citation>
      </ref>
      <ref id="B41-biomolecules-05-01319">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bleier</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Dr&#xF6;se</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Superoxide generation by complex III: From mechanistic rationales to functional consequences</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2013</year>
          <volume>1827</volume>
          <fpage>1320</fpage>
          <lpage>1331</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbabio.2012.12.002</pub-id>
          <pub-id pub-id-type="pmid">23269318</pub-id>
        </citation>
      </ref>
      <ref id="B42-biomolecules-05-01319">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>M.P.</given-names>
            </name>
          </person-group>
          <article-title>How mitochondria produce reactive oxygen species</article-title>
          <source>Biochem. J.</source>
          <year>2009</year>
          <volume>417</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1042/BJ20081386</pub-id>
          <pub-id pub-id-type="pmid">19061483</pub-id>
        </citation>
      </ref>
      <ref id="B43-biomolecules-05-01319">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picard</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Taivassalo</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gouspillou</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hepple</surname>
              <given-names>R.T.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondria: Isolation, structure and function</article-title>
          <source>J. Physiol.</source>
          <year>2011</year>
          <volume>589</volume>
          <fpage>4413</fpage>
          <lpage>4421</lpage>
          <pub-id pub-id-type="doi">10.1113/jphysiol.2011.212712</pub-id>
          <pub-id pub-id-type="pmid">21708903</pub-id>
        </citation>
      </ref>
      <ref id="B44-biomolecules-05-01319">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picard</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Taivassalo</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ritchie</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Romestaing</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hepple</surname>
              <given-names>R.T.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial structure and function are disrupted by standard isolation methods</article-title>
          <source>PLoS ONE</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e18317</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0018317</pub-id>
          <pub-id pub-id-type="pmid">21512578</pub-id>
        </citation>
      </ref>
      <ref id="B45-biomolecules-05-01319">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eigentler</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fontana-Ayoub</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>O2k-Fluorometry: HRR and H<sub>2</sub>O<sub>2</sub> production in mouse cardiac tissue homogenate</article-title>
          <source>Mitochondr. Physiol. Network</source>
          <year>2013</year>
          <volume>18</volume>
          <fpage>1</fpage>
          <lpage>6</lpage>
        </citation>
      </ref>
      <ref id="B46-biomolecules-05-01319">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gross</surname>
              <given-names>V.S.</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Baranov</surname>
              <given-names>S.V.</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Stavrovskaya</surname>
              <given-names>I.G.</given-names>
            </name>
            <name>
              <surname>Lazarev</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Kristal</surname>
              <given-names>B.S.</given-names>
            </name>
          </person-group>
          <article-title>Isolation of functional mitochondria from rat kidney and skeletal muscle without manual homogenization</article-title>
          <source>Anal. Biochem.</source>
          <year>2011</year>
          <volume>418</volume>
          <fpage>213</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ab.2011.07.017</pub-id>
          <pub-id pub-id-type="pmid">21820998</pub-id>
        </citation>
      </ref>
      <ref id="B47-biomolecules-05-01319">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tahara</surname>
              <given-names>E.B.</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Netto</surname>
              <given-names>L.E.</given-names>
            </name>
            <name>
              <surname>Kowaltowski</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Dihydrolipoyl dehydrogenase as a source of reactive oxygen species inhibited by caloric restriction and involved in <italic>Saccharomyces cerevisiae</italic> aging</article-title>
          <source>FASEB J.</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>274</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="doi">10.1096/fj.06-6686com</pub-id>
          <pub-id pub-id-type="pmid">17110466</pub-id>
        </citation>
      </ref>
      <ref id="B48-biomolecules-05-01319">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seaver</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Imlay</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Are respiratory enzymes the primary sources of intracellular hydrogen peroxide?</article-title>
          <source>J. Biol. Chem.</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>48742</fpage>
          <lpage>48750</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M408754200</pub-id>
          <pub-id pub-id-type="pmid">15361522</pub-id>
        </citation>
      </ref>
      <ref id="B49-biomolecules-05-01319">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y.R.</given-names>
            </name>
            <name>
              <surname>Zweier</surname>
              <given-names>J.L.</given-names>
            </name>
          </person-group>
          <article-title>Cardiac mitochondria and reactive oxygen species generation</article-title>
          <source>Circ. Res.</source>
          <year>2014</year>
          <volume>114</volume>
          <fpage>524</fpage>
          <lpage>537</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.114.300559</pub-id>
          <pub-id pub-id-type="pmid">24481843</pub-id>
        </citation>
      </ref>
      <ref id="B50-biomolecules-05-01319">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pesta</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gnaiger</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2012</year>
          <volume>810</volume>
          <fpage>25</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">22057559</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
